Peripheral T-cell lymphomas: A review of current approaches and hopes for the future

Alan P. Skarbnik; Meher Burki; Barbara Pro

doi:10.3389/fonc.2013.00138

Peripheral T-cell lymphomas: A review of current approaches and hopes for the future

Alan P. Skarbnik, Meher Burki, Barbara Pro^*

^*Corresponding author for this work

Medicine, Hematology Oncology Division

Research output: Contribution to journal › Review article › peer-review

11 Scopus citations

Abstract

Peripheral T-cell lymphomas (PTCL) are a diverse group of lymphoproliferative disorders, which share a common denominator of overall poor prognosis, with few exceptions. In this article, the authors review current standard of care approaches for the treatment of PTCLs, the role of stem-cell/bone marrow transplantation, and current developments in novel targeted therapies.

Original language	English (US)
Article number	Article 138
Journal	Frontiers in Oncology
Volume	3 MAY
DOIs	https://doi.org/10.3389/fonc.2013.00138
State	Published - 2013

Keywords

ALCL
Alisertib
Bortezomib
Brentuximab
PTCL
Pralatrexate
Romidepsin
Zanolimumab

ASJC Scopus subject areas

Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3389/fonc.2013.00138

Cite this

@article{3458038a32954a9086bf93973454671e,

title = "Peripheral T-cell lymphomas: A review of current approaches and hopes for the future",

abstract = "Peripheral T-cell lymphomas (PTCL) are a diverse group of lymphoproliferative disorders, which share a common denominator of overall poor prognosis, with few exceptions. In this article, the authors review current standard of care approaches for the treatment of PTCLs, the role of stem-cell/bone marrow transplantation, and current developments in novel targeted therapies.",

keywords = "ALCL, Alisertib, Bortezomib, Brentuximab, PTCL, Pralatrexate, Romidepsin, Zanolimumab",

author = "Skarbnik, {Alan P.} and Meher Burki and Barbara Pro",

year = "2013",

doi = "10.3389/fonc.2013.00138",

language = "English (US)",

volume = "3 MAY",

journal = "Frontiers in Oncology",

issn = "2234-943X",

publisher = "Frontiers Media S. A.",

}

TY - JOUR

T1 - Peripheral T-cell lymphomas

T2 - A review of current approaches and hopes for the future

AU - Skarbnik, Alan P.

AU - Burki, Meher

AU - Pro, Barbara

PY - 2013

Y1 - 2013

N2 - Peripheral T-cell lymphomas (PTCL) are a diverse group of lymphoproliferative disorders, which share a common denominator of overall poor prognosis, with few exceptions. In this article, the authors review current standard of care approaches for the treatment of PTCLs, the role of stem-cell/bone marrow transplantation, and current developments in novel targeted therapies.

AB - Peripheral T-cell lymphomas (PTCL) are a diverse group of lymphoproliferative disorders, which share a common denominator of overall poor prognosis, with few exceptions. In this article, the authors review current standard of care approaches for the treatment of PTCLs, the role of stem-cell/bone marrow transplantation, and current developments in novel targeted therapies.

KW - ALCL

KW - Alisertib

KW - Bortezomib

KW - Brentuximab

KW - PTCL

KW - Pralatrexate

KW - Romidepsin

KW - Zanolimumab

UR - http://www.scopus.com/inward/record.url?scp=84891076403&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84891076403&partnerID=8YFLogxK

U2 - 10.3389/fonc.2013.00138

DO - 10.3389/fonc.2013.00138

M3 - Review article

C2 - 23755375

AN - SCOPUS:84891076403

SN - 2234-943X

VL - 3 MAY

JO - Frontiers in Oncology

JF - Frontiers in Oncology

M1 - Article 138

ER -

Peripheral T-cell lymphomas: A review of current approaches and hopes for the future

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this